Nutrapharm launches Setria-powered supplement, marking a regulatory milestone for the clinically researched ingredient in South America NEW YORK, June 11, 2026 /PRNewswire/ -- Kyowa Hakko, a global leader in health ingredient innovation and manufacturer of branded ingredient Setria Glutathione, today announced that a supplement featuring Setria has been approved for sale in Chile through the Secretara Regional Ministerial (SEREMI) de Salud
Versatile Application: Suitable for a variety of studies, including those related to anabolic therapies, performance enhancement, and metabolic health
Whilst study findings seem to not support folate genotype being selected to enhance DNA repair pathways in high UVR environments, the relationship between UVR and folate is proposed to have a role in strengthening our epidermal barrier
Glutathione supplementation as an adjunctive therapy in COVID-19
Highly specific for growth hormone release, with minimal effect on other hormones